EFFECTIVELY SELECTING A TARGET POPULATION FOR A FUTURE COMPARATIVE STUDY.

Area of Science:

• Clinical Trials Methodology
• Biostatistics
• Translational Medicine

Background:

• Randomized clinical trials (RCTs) rely on appropriate study populations for accurate treatment effect assessment.
• Identifying subgroups that benefit most from new treatments is crucial for trial success and personalized medicine.

Purpose of the Study:

• To develop a systematic method for identifying patient subpopulations with expected benefits from new treatments using existing data.
• To enable targeted treatment strategies by defining patient subgroups based on predicted treatment differences.

Main Methods:

• Developed a parametric scoring system using baseline covariates to estimate subject-specific treatment differences.
• Utilized a cross-training-evaluation method to avoid bias and select optimal scoring models.
• Constructed empirically calibrated curves to identify subpopulations based on desired treatment benefit levels.

Main Results:

• Demonstrated a method to define patient subgroups likely to experience desired treatment benefits.
• Illustrated the procedure's utility with data from HIV and cardiovascular disease clinical trials.
• Showcased the method's applicability for both new trial design and future patient management.

Conclusions:

• The proposed method offers a robust approach to identifying promising patient populations for clinical trials.
• This strategy enhances treatment targeting, potentially improving therapeutic efficacy and resource allocation.
• The findings support optimizing clinical trial design and guiding personalized treatment decisions in clinical practice.